Co-Diagnostics Stock (NASDAQ: CODX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 59.571K |
Day Range | - - - |
52 Wk Range | 0.975 - 1.890 |
Market Cap | $39.384M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 1.63% |
Days to Cover | 8.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Co-Diagnostics (NASDAQ: CODX) through any online brokerage.
Other companies in Co-Diagnostics’s space includes: LENSAR (NASDAQ:LNSR), Talis Biomedical (NASDAQ:TLIS), Modular Medical (NASDAQ:MODD), QT Imaging Holdings (NASDAQ:QTI) and Lucid Diagnostics (NASDAQ:LUCD).
The latest price target for Co-Diagnostics (NASDAQ: CODX) was reported by HC Wainwright & Co. on Friday, March 15, 2024. The analyst firm set a price target for 2.50 expecting CODX to rise to within 12 months (a possible 98.43% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Co-Diagnostics (NASDAQ: CODX) is $1.2599 last updated April 12, 2024 at 5:57 PM EDT.
There are no upcoming dividends for Co-Diagnostics.
Co-Diagnostics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Co-Diagnostics.
Co-Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.